Virax Biolabs Group Ownership | Who Owns Virax Biolabs Group?

Virax Biolabs Group Ownership Summary

Virax Biolabs Group is owned by 0.29% institutional investors, and 99.71% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Virax Biolabs Group shares.

VRAX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Virax Biolabs Group	0.29%	-	99.71%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2023	4	-	33,509	-41.56%	-	115.93%	3	-	-	-100.00%
Jun 30, 2023	4	-20.00%	57,338	-96.51%	-	0.24%	3	-	1	-50.00%
Mar 31, 2023	5	-37.50%	1,643,242	443.39%	14	204.38%	3	-57.14%	2	100.00%
Dec 31, 2022	8	100.00%	302,403	418.05%	2	1009.45%	7	75.00%	1	-
Sep 30, 2022	4	-	58,373	-	-	-	4	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	542.00	0.01%	-

VRAX Ownership FAQ

Who Owns Virax Biolabs Group?

Virax Biolabs Group shareholders are primarily institutional investors at 0.29%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Virax Biolabs Group's industry, Biotech Stocks , is 44.97%, which Virax Biolabs Group falls below.

Does Blackrock own Virax Biolabs Group?

BlackRock is not among the top 10 institutional shareholders of Virax Biolabs Group.

Who is the top mutual fund holder of Virax Biolabs Group shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Virax Biolabs Group shares, with 0.01% of its total shares outstanding invested in 542 Virax Biolabs Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools